Epsilon M&A Deal Report - Evalve
Transaction Multiples for the Valuation of Private Companies
Abbott Laboratories / Evalve
No EMAT :
22342
Announced Date :
10/09/2009
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Abbott Laboratories
Target :
Evalve
Country :
United States
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Implants or Prostheses Manufacturers
Business Description :
Founded in 1999, Evalve Inc engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves . The company provides a non-surgical mitral valve...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Implants or Prostheses Manufacturers » = 63
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/01/2010 | Medtronic | Invatec | Italy | *** | 22340 |
| 10/11/2010 | Private Group Led by Ergon Capital Partners | Elitech Groupe | France | * | 22168 |
Source: Epsilon Research / EMAT
